HR 601
116th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Health programs administration and funding
Licensing and registrations
Medical research
Veterans' medical care
Medical Cannabis Research Act of 2019
Introduced: January 16, 2019
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 4, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Feb 8, 2019
Referred to the Subcommittee on Health.
Jan 25, 2019
Referred to the Subcommittee on Health.
Jan 16, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 16, 2019
Introduced in House
Plain-English summary
Medical Cannabis Research Act of 2019
This bill establishes a new, separate registration process for manufacturers of cannabis for research.
As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.
The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.